These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9265449)

  • 21. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socio-economic deprivation and survival in bladder cancer.
    Begum G; Dunn JA; Bryan RT; Bathers S; Wallace DM;
    BJU Int; 2004 Sep; 94(4):539-43. PubMed ID: 15329108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
    Walz J; Shariat SF; Suardi N; Perrotte P; Lotan Y; Palapattu GS; Gupta A; Bastian PJ; Rogers CG; Vazina A; Amiel GE; Sagalowsky AI; Schoenberg M; Lerner SP; Karakiewicz PI
    BJU Int; 2008 Jun; 101(11):1356-61. PubMed ID: 18454792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
    Tracey E; Roder D; Luke C; Bishop J
    BJU Int; 2009 Aug; 104(4):498-504. PubMed ID: 19338538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
    Daneshmand S; Stein JP; Lesser T; Quek ML; Nichols PW; Miranda G; Cai J; Groshen S; Skinner EC; Skinner DG
    J Urol; 2004 Jul; 172(1):81-4. PubMed ID: 15201742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
    Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M
    Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
    Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W
    J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
    J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of survival after cystectomy for bladder cancer. Report of 504 cases].
    Lebret T; Hervé JM; Yonneau L; Barré P; Lugagne PM; Butreau M; Molinié V; Botto H
    Prog Urol; 2000 Sep; 10(4):553-60. PubMed ID: 11064896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A clinical study of superficial bladder cancer with grade 3 components].
    Iiyama T; Hariu K; Kawai M; Kamiyama Y; Okano Y; Shimizu H; Tomomasa H; Iizumi T; Yazaki T; Umeda T
    Hinyokika Kiyo; 1998 Jun; 44(6):375-9. PubMed ID: 9719934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
    Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
    J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
    J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.
    Herr HW; Donat SM
    J Urol; 1999 Jun; 161(6):1854-7. PubMed ID: 10332452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplicity and history have a detrimental effect on survival of patients with T1G3 bladder tumors selected for conservative treatment.
    Serretta V; Ruggirello A; Dispensa N; Allegro R; Aragona F; Melloni D
    J Urol; 2008 Sep; 180(3):886-90; discussion 891. PubMed ID: 18635223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.
    Lambert EH; Pierorazio PM; Olsson CA; Benson MC; McKiernan JM; Poon S
    BJU Int; 2007 Jul; 100(1):33-6. PubMed ID: 17552951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.